Yamamoto M - Search Results

1

Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors.

Hirayama R, Yamamoto M, Tsukida T, Matsuo K, Obata Y, Sakamoto F, Ikeda S. Hirayama R, et al. Among authors: yamamoto m. Bioorg Med Chem. 1997 Apr;5(4):765-78. doi: 10.1016/s0968-0896(97)00028-x. Bioorg Med Chem. 1997. PMID: 9158875

2

Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.

Yamamoto M, Tsujishita H, Hori N, Ohishi Y, Inoue S, Ikeda S, Okada Y. Yamamoto M, et al. J Med Chem. 1998 Apr 9;41(8):1209-17. doi: 10.1021/jm970404a. J Med Chem. 1998. PMID: 9548812

3

Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-alpha processing.

Yamamoto M, Hirayama R, Naruse K, Yoshino K, Shimada A, Inoue S, Kayagaki N, Yagita H, Okumura K, Ikeda S. Yamamoto M, et al. Drug Des Discov. 1999 Aug;16(2):119-30. Drug Des Discov. 1999. PMID: 10533808 Review.

4

Surgical anatomy for the extended middle cranial fossa approach.

Ogawa K, Inoue Y, Yamamoto M, Ikeda S, Kanzaki J. Ogawa K, et al. Among authors: yamamoto m. Acta Otolaryngol Suppl. 1991;487:41-7. doi: 10.3109/00016489109130444. Acta Otolaryngol Suppl. 1991. PMID: 1843584

5

Hearing recovery and vestibular symptoms in patients with sudden deafness and profound hearing loss.

Yamamoto M, Kanzaki J, Ogawa K, Inoue Y, Ikeda S. Yamamoto M, et al. Acta Otolaryngol Suppl. 1994;514:41-4. doi: 10.3109/00016489409127556. Acta Otolaryngol Suppl. 1994. PMID: 8073883

6

Non-radioactive hybridization probes prepared using M13 phage vector and the universal sequencing primer.

Ikeda S, Yamamoto M, Nagao K, Zhang B, Watanabe S, Oda T. Ikeda S, et al. Among authors: yamamoto m. Acta Med Okayama. 1989 Aug;43(4):197-202. doi: 10.18926/AMO/30857. Acta Med Okayama. 1989. PMID: 2678902

7

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.

Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Shimada K, Ito S, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Kimura G, Umemura S, Ura N, Hayashi K, Odawara M, Tanahashi N, Ishimitsu T, Kashihara N, Morita S, Teramukai S; COLM Investigators. Ogihara T, et al. J Hypertens. 2014 Oct;32(10):2054-63; discussiom 2063. doi: 10.1097/HJH.0000000000000281. J Hypertens. 2014. PMID: 24999799 Free PMC article. Clinical Trial.

8

Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site.

Sakaguchi M, Hirayama Y, Maeda H, Matsuo K, Yamamoto M, Hirai K. Sakaguchi M, et al. Among authors: yamamoto m. Vaccine. 1994 Aug;12(10):953-7. doi: 10.1016/0264-410x(94)90040-x. Vaccine. 1994. PMID: 7975837

9

Audiological findings in acoustic neuroma.

Kanzaki J, Ogawa K, Ogawa S, Yamamoto M, Ikeda S, O-Uchi T. Kanzaki J, et al. Among authors: yamamoto m. Acta Otolaryngol Suppl. 1991;487:125-32. doi: 10.3109/00016489109130457. Acta Otolaryngol Suppl. 1991. PMID: 1843574

10

The growth rate of acoustic neuromas.

Ogawa K, Kanzaki J, Ogawa S, Yamamoto M, Ikeda S, Shiobara R. Ogawa K, et al. Among authors: yamamoto m. Acta Otolaryngol Suppl. 1991;487:157-63. doi: 10.3109/00016489109130462. Acta Otolaryngol Suppl. 1991. PMID: 1843579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,348 results

Search Page

Filters